Alternative statutory remedy and unexplained delay barred writ review of customs confiscation adjudication, leaving merits for appellate consideration...
Authorised courier due diligence protects against penalties where declared exports conceal prohibited goods despite proper documentation and customs p...
Customs-controlled container movement now extends to DP World facilities, subject to segregation, inspections, reconciliation, and EXIM cargo priority...
CESTAT determined classification of imported glucose monitoring devices under CTH 9027 80 90, affirming prior judicial precedents from Bayer Pharmaceuticals case and Bombay HC ruling. The tribunal upheld classification under scientific instrument heading, which qualifies for NIL Basic Customs Duty (BCD) under Notification No. 24/2005-Cus. The revenue's appeal was dismissed, confirming the concessional duty rate for goods classified under CTH 9027, distinguishing them from medical instruments under CTH 9018. The decision reinforces the specific tariff classification principles for medical diagnostic equipment, granting the appellant the benefit of zero customs duty based on the precise product categorization.
CESTAT determined classification of imported glucose monitoring devices under CTH 9027 80 90, affirming prior judicial precedents from Bayer Pharmaceuticals case and Bombay HC ruling. The tribunal upheld classification under scientific instrument heading, which qualifies for NIL Basic Customs Duty (BCD) under Notification No. 24/2005-Cus. The revenue's appeal was dismissed, confirming the concessional duty rate for goods classified under CTH 9027, distinguishing them from medical instruments under CTH 9018. The decision reinforces the specific tariff classification principles for medical diagnostic equipment, granting the appellant the benefit of zero customs duty based on the precise product categorization.
Note: It is a system-generated summary and is for quick reference only.